RALPH NIVEN
CIK 1168060 · CHIEF SCIENTIFIC OFFICER · last filed 2024-02-07
RALPH NIVEN is a CHIEF SCIENTIFIC OFFICER who has filed 19 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing, for AVTE, was dated Feb 7, 2024. Across all open-market trades the lifetime net is −$989.4K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
19
-$989.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Jade Biosciences, Inc. (AVTE) Delisted | CHIEF SCIENTIFIC OFFICER | 3,009 | $93.80 | $282.2K | -$989.4K | 19 | 2024-02-07 |
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-02-07 | Jade Biosciences, Inc. (AVTE) Delisted | Mixed | — | -$71.0K | EDGAR |
| 2024-01-24 | Jade Biosciences, Inc. (AVTE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-01-08 | Jade Biosciences, Inc. (AVTE) Delisted | Mixed | — | -$78.8K | EDGAR |
| 2023-12-07 | Jade Biosciences, Inc. (AVTE) Delisted | Mixed | — | -$65.7K | EDGAR |
| 2023-11-27 | Jade Biosciences, Inc. (AVTE) Delisted | Mixed | — | -$179.1K | EDGAR |
| 2023-07-07 | Jade Biosciences, Inc. (AVTE) Delisted | Mixed | — | -$34.4K | EDGAR |
| 2023-06-07 | Jade Biosciences, Inc. (AVTE) Delisted | Mixed | — | -$32.0K | EDGAR |
| 2023-05-09 | Jade Biosciences, Inc. (AVTE) Delisted | Mixed | — | -$42.4K | EDGAR |
| 2023-04-07 | Jade Biosciences, Inc. (AVTE) Delisted | Mixed | — | -$36.4K | EDGAR |
| 2023-03-08 | Jade Biosciences, Inc. (AVTE) Delisted | Mixed | — | -$48.9K | EDGAR |